Diana F. Hausman - 21 Jun 2022 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Diana F. Hausman
Issuer symbol
IMRX
Transactions as of
21 Jun 2022
Net transactions value
$0
Form type
4
Filing time
23 Jun 2022, 16:56:31 UTC
Previous filing
18 Jan 2022
Next filing
10 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +6,185 $0.000000 6,185 21 Jun 2022 Class A Common Stock 6,185 $4.63 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 21, 2022, and will be fully vested and exercisable on June 21, 2023, or the date of the 2023 annual meeting of stockholders, whichever comes first.